Sutent and Fentanyl-100 drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Sutent (sunitinib malate) and Fentanyl-100 (fentanyl). Common drug interactions include toxic epidermal necrolysis among females and osteonecrosis of jaw among males.

The phase IV clinical study analyzes what interactions people have when they take Sutent and Fentanyl-100. It is created by eHealthMe based on reports of 11 people who take the same drugs from the FDA, and is updated regularly.

What is Sutent?

Sutent has active ingredients of sunitinib malate. It is often used in renal cell carcinoma. eHealthMe is studying from 44,554 Sutent users. Check the latest studies of Sutent.

What is Fentanyl-100?

Fentanyl-100 has active ingredients of fentanyl. It is often used in pain. eHealthMe is studying from 7,047 Fentanyl-100 users. Check the latest studies of Fentanyl-100.

On Jul, 27, 2026

11 people who take Sutent and Fentanyl-100 together, and have interactions are studied.

Sutent and Fentanyl-100 drug interactions.

What are the common drug interactions of Sutent and Fentanyl-100, by gender? *:

female:

Toxic epidermal necrolysis (a rare, life-threatening skin condition that is usually caused by a reaction to drugs causes wide spread skin destruction)

male:

Osteonecrosis of jaw (death of bone of jaw)
Anaemia (lack of blood)
Respiratory failure (inadequate gas exchange by the respiratory system)
Dermatitis contact (skin reaction (dermatitis) resulting from exposure to allergens)
Abdominal pain
Arteriosclerosis (thickening and hardening of arteries)
Cellulitis (infection under the skin)
Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
Haematemesis (vomiting of blood)
Haematochezia (passage of stools containing blood)

What are the common drug interactions of Sutent and Fentanyl-100, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

Dermatitis contact (skin reaction (dermatitis) resulting from exposure to allergens)
Interstitial lung disease

30-39:

n/a

40-49:

Constipation
Death

50-59:

Bone lesion (bone with abnormalities. bone lesions can result from growth formations, infections, or injuries)
Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
Exposed bone in jaw
General physical health deterioration (weak health status)
Jaw fracture
Leukopenia (less number of white blood cells in blood)
Metastases to bone (cancer spreads to bone)
Metastases to lung (cancer spreads to lung)
Neoplasm malignant (cancer tumour)
Neoplasm progression (growth of tumour)

60+:

Abdominal pain
Anxiety
Osteonecrosis of jaw (death of bone of jaw)
Pleural effusion (water on the lungs)
Pulmonary oedema (fluid accumulation in the lungs)
Respiratory failure (inadequate gas exchange by the respiratory system)
Toxic epidermal necrolysis (a rare, life-threatening skin condition that is usually caused by a reaction to drugs causes wide spread skin destruction)
Abdominal discomfort
Actinic keratosis (skin disease due to sun exposure)
Agitation (state of anxiety or nervous excitement)

What are the existing conditions these people have? *

Neoplasm Malignant (cancer tumour): 2 people, 18.18%
Prostate Cancer: 1 person, 9.09%
Pancreatic Neuroendocrine Tumor: 1 person, 9.09%
Nausea And Vomiting: 1 person, 9.09%
Metastatic Renal Cell Carcinoma (spreadable kidney cell tumour): 1 person, 9.09%
Insomnia (sleeplessness): 1 person, 9.09%
Indigestion: 1 person, 9.09%
Gastrointestinal Stromal Tumor: 1 person, 9.09%
Depression: 1 person, 9.09%
Constipation: 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Sutent and Fentanyl-100?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously